Aquestive Therap
Stock
Stock
Ticker: AQST
AQST
Price
Price
CHART BY
Frequently asked questions
What is Aquestive Therap's market capitalization?
The market capitalization of Aquestive Therap is $578.61M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Aquestive Therap?
Aquestive Therap's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.65. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Aquestive Therap's stock?
Currently, 9 analysts cover Aquestive Therap's stock, with a consensus target price of $9.333. Analyst ratings provide insights into the stock's expected performance.
What is Aquestive Therap's revenue over the trailing twelve months?
Over the trailing twelve months, Aquestive Therap reported a revenue of $54.09M.
What is the EBITDA for Aquestive Therap?
Aquestive Therap's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$52.22M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Aquestive Therap?
Aquestive Therap has a free cash flow of -$45.95M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Aquestive Therap have, and what sector and industry does it belong to?
Aquestive Therap employs approximately 147 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Aquestive Therap's shares?
The free float of Aquestive Therap is 109.85M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $578.61M
- EPS (TTM)
- -$0.65
- Free Float
- 109.85M
- Revenue (TTM)
- $54.09M
- EBITDA (TTM)
- -$52.22M
- Free Cashflow (TTM)
- -$45.95M
Pricing
- 52W span
- $2.93$7.54
Analyst Ratings
The price target is $9.333 and the stock is covered by 9 analysts.
Buy
9
Hold
0
Sell
0
Information
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
- Employees
- 147
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- AQST
Fundamentals & EOD data from FactSet